Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE

INTRODUCTION: CHOICE (CHanges to treatment and Outcomes in patients with type 2 diabetes initiating InjeCtablE therapy; NCT00635492) assessed, as its primary objective, the time to a ‘significant treatment change’ (defined within this paper) after patients with type 2 diabetes mellitus initiated the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mathieu, Chantal, Östenson, Claes-Göran, Matthaei, Stephan, Reaney, Matthew, Krarup, Thure, Guerci, Bruno, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Theodorakis, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3889314/
https://ncbi.nlm.nih.gov/pubmed/24018835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-013-0037-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados